In a recent study conducted at the Baylor College of Medicine, Houston, USA, scientists have identified six vaccine breakthrough cases caused by the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
A vaccine breakthrough case is defined as the detection of SARS-CoV-2 infection in individuals who are fully vaccinated against coronavirus disease 2019 (COVID-19). The study is currently available on the medRxiv* preprint server.
Background
Recently, India has seen a significant rise in new COVID-19 cases predominantly caused by the delta variant (B.1.617.2) of SARS-CoV-2. Similar to the alpha (B.1.1.7), beta (B.1.351), and gamma (P.1) variants, the delta variant has gained beneficial mutations in the spike protein, which make it more infectious and pathogenic than previously circulating variants.
The delta variant belongs to the B.1.617 lineage that is currently circulating in more than 50 countries. Because of its significant threat to public health, the delta variant has been designated as the Variant of Concern (VOC) by the World Health Organization.
Studies investigating vaccine efficacy against emerging SARS-CoV-2 variants have indicated that the delta variant is partially resistant to vaccine-induced antibodies. A study conducted in the UK has indicated that the Pfizer/BioNTech COVID-19 vaccines is 88% effective in preventing symptomatic disease caused by the delta variant.
In the current study, the scientists have described the transmission of delta variants among family members who were attending a wedding ceremony with 92 guests. The wedding events were held outside in a large open-air tent, and all guests were fully vaccinated.
Important observations
The scientists identified a total of six individuals at the wedding ceremony who tested positive for SARS-CoV-2 and were symptomatic. Of them, one developed severe COVID-19 requiring monoclonal antibody infusion and one died eventually. Based on encounter timings and viral sequence similarities, the scientists suggested that two persons traveling from India probably have transmitted the delta variant to other guests during the wedding events.
Soon after developing symptoms including fatigue, cough, and fever, both guests from India tested positive for SARS-CoV-2 infection. At day 6 post-wedding, the man without comorbidity was admitted to a hospital because of worsening symptoms. One month after the wedding, he died due to COVID-19 related complications.
Four other guests who also tested positive for SARS-CoV-2 had confirmed interactions with the guests from India. Of 4 guests who were fully immunized with the Pfizer/BioNTech or Moderna COVID-19 vaccine, one developed severe COVID-19 that required infusion of monoclonal antibodies.
Testing of viral variant
Nasopharyngeal swab samples were collected from all six guests and analyzed by reverse transcription-polymerase chain reaction (RT-PCR) to detect viral variants. All samples tested positive for the original Wuhan strain of SARS-CoV-2 and negative for the alpha variant. All positive samples were subsequently sequenced by Swift Normalase Amplicon Panels with multiple overlapping amplicons to identify the causative variant. The findings revealed that all six guests were infected with the delta variant of SARS-CoV-2 (B.1.617.2).
News
Hundreds of AI tools have been built to catch covid – None of them helped
When covid-19 struck Europe in March 2020, hospitals were plunged into a health crisis that was still badly understood. “Doctors really didn’t have a clue how to manage these patients,” says Laure Wynants, an [...]
Two doses of Pfizer, AstraZeneca COVID-19 shots effective against delta variant, study finds
Pfizer found to be 88 per cent effective at preventing symptomatic disease from delta variant. Two doses of Pfizer-BioNTech or AstraZeneca-Oxford's COVID-19 vaccines are nearly as effective against the highly transmissible delta coronavirus variant [...]
S.Africa’s Aspen releases first batch of Johnson vaccine
South African pharmaceutical company Aspen said Monday it was releasing its first batch of African-produced COVID-19 vaccines under a licensing deal with the US giant Johnson & Johnson. The Durban-based company said the first [...]
COVID-19 Variants: What the Future Could Look Like After the Pandemic
Since the coronavirus pandemic shut down the world, scientists have clamored to develop vaccines to prevent the spread and medicines that will cure the sick. But a virus’ main goal is to replicate and [...]
Delta variant of SARS-CoV-2 will likely be dominant strain globally within months
The highly transmissible delta variant of SARS-CoV-2, the coronavirus causing the disease COVID-19, is now present in 124 countries and will become the dominant strain globally in the coming months as it is outcompeting [...]
UK scientists back Covid boosters as study finds post-jab falls in antibodies
Scientists have backed proposals for Covid boosters in the autumn after blood tests on hundreds of people revealed that protective antibodies can wane substantially within weeks of second vaccine shots being given. Falls in [...]
Pfizer-BioNTech and Moderna COVID-19 vaccines establish recall responses to reinfection
Researchers in the United States have conducted a study showing that the coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna generate a coordinated adaptive immune response that is capable of eliciting recall [...]
Study shows new ‘warm vaccine’ effective against all key virus variants
CSIRO, Australia's national science agency, played an important role in evaluating heat-tolerant COVID-19 vaccine formulations developed by the Indian Institute of Science (IISc) and biotech start-up Mynvax—against all current SARS-CoV-2 variants of concern. Published [...]
Podcast – Nanovisaging 2040 How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit Humanity
Frank Boehm (NanoApps Medical Inc. Founder) in discussion with Nana Kay in a Wealth Secrets podcast. EP 19. Nanovisaging 2040. From Nana Kay: Nanovisaging 2040: How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit [...]
Data in favour of mixing COVID-19 vaccines, but long-term effects unknown
Canada, like several other countries, has been mixing and matching COVID-19 vaccines for weeks amid safety concerns over the AstraZeneca shot. On Monday, the chief scientist at the World Health Organization (WHO) cautioned against that approach, calling [...]
CRISPR stops coronavirus replication in human cells
Scientists have harnessed CRISPR gene-editing technology to block the replication of the novel coronavirus in human cells — an approach that could one day serve as a new treatment for COVID-19. However, the study was performed [...]
Controlling the Size of Nanoparticles
Depositing nanoparticles using the NL50 is now simpler than ever with the pre-loaded optimized recipes for a variety of frequently used materials, including Au, Ag, Pt and Cu. These optimized recipes generate high-quality nano-coatings [...]
Shape of Nanoparticles in Body Fluids – a Biomarker for Identifying Cancer Types?
A recent study by scientists from Japanese universities has shown that the shape of cell-derived nanoparticles, known as "extracellular vesicles" (EVs), in body fluids could be a biomarker for identifying types of cancer. In [...]
Study reveals how our immune system reacts to COVID-19 variants
An important lesson for vaccine design Australian scientists researching how our immune system responds to COVID-19 have revealed that those infected by early variants in 2020 produced sustained antibodies, however, these antibodies are not [...]
COVID-19: What you need to know about the coronavirus pandemic on 8 July
1. How COVID-19 is affecting the globe Confirmed cases of COVID-19 have passed 185 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4 million. More than 3.29 [...]
Here’s what you should know about the Lambda variant
The World Health Organization (WHO) has added another COVID strain to its list of coronavirus variants to keep an eye on: the COVID-19 Lambda variant. This particular variant has now spread to more than two dozen [...]
